Urinary Incontinence
Conditions
Brief summary
Previous studies Results show (PRP) is safe and effective in treating SUI, other studies show the result of energy base devices (Co2 laser, HIFU) are effective in treating of SUI . This study add the effect both HIFU and PRP together in treating SUI.
Detailed description
What is stress urinary incontinence (SUI)? Stress urinary incontinence (SUI) is when urine leaks out with sudden pressure on the bladder and urethra, causing the sphincter muscles to open briefly. With mild SUI, pressure may be from sudden forceful activities, like exercise, sneezing, laughing or coughing. If your SUI is more severe, you may also leak with less forceful activities like standing up, walking or bending over. Urinary accidents like this can range from a few drops of urine to enough to soak through the clothes SUI is a very common bladder problem for women. Key SUI statics About half of women age 65 and above find that they sometimes leak urine. How can SUI Affect life? Many people find that SUI gets in the way of daily and social activities. It can affect family and sexual relationships. Some people even begin to feel isolated and hopeless because of it The pelvic floor supports the bladder and urethra. If this area gets stretched, weakened or damaged, then SUI can happen. Pregnancy and childbirth can cause this. PRP is extremely rich in growth factors and cytokines which regulate tissue reconstruction, PRP is an easily procedure and relatively inexpensive biological material, it is produce directly from patient blood and inject PRP under urethra to restore bulbourethral ligment . HIFU is an energy-based medical technology with many clinical applications, a device is a non-invasive procedure that provides collagen remodeling and synthesis that may repair and restore pelvic floor and pubourethral ligment, it is non-invasive therapeutic technique, that uses non-ionized ultrasonic waves that provides collagen that tight the endopelvic fascia and adjacent tissues .
Interventions
DEVICEPRP injection
Active comparator: PRP 3 cycles of platelet-rich plasma injection treatment in 4 weeks intervals. Procedure: PRP injection of 2ml platelet-rich plasma from centrifuged for 5 min patient's blood under the urethra. Cycle patient will examined and asked to fill daily micturition plan International consolation on incontinence questionnaire-urinary incontinence short form (ICIQ UI SF), urogenital distress inventory (UDI-6), incontinence impact questionnaire (11Q-7) and over active bladder symptoms scores (OABSS).
DEVICEHifu procedure and PRP injection
Procedure: PRP injection of 2ml platelet-rich plasma from centrifuged for 5 min patient's blood under urethra.And intravaginal Hifu in4 weeks intervals. Cycle patient will examined and asked to fill daily micturition plan International consolation on incontinence questionnaire-urinary incontinence short form (ICIQ UI SF), urogenital distress inventory (UDI-6), incontinence impact questionnaire (11Q-7) and over active bladder symptoms scores (OABSS).
Sponsors
Ain Shams Maternity Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
FEMALE
Age
30 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Women complain of SUI is the symptom of urinary leakage due to increased abdominal pressure, which can be caused by activities such as sneezing, coughing, exercise, lifting, and position change (American Urological Association 2017). * Positive cough test when filled urinary bladder. * Women chose non-invasive management rather than surgical management. • • Among the 20 patients enrolled, the average age was 30-60 years old. * Urodynamic study proven the diagnosis.
Exclusion criteria
* Patient of previous operation or radiation * Uncontrolled diabetes Neuromuscular disorder * Uncontrolled psychiatric diseases * Pregnancy * Lactation * Virgin * Sepsis * Active carcinoma * Cystocele. * Antiplatelet drug intake less than 7 days before and after procedure. - bleeding disorder. * Patients cannot deal with Questionnaires.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| After one month of first session, the rate of Improvement of the stress urinary incontinence increased . | One month after first session | Self-reported questionnaires were used to measure pre-Treatment symptom severity and post treatment symptom and severity. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| one month after complete three sessions ,the rate of Improvement of the urinary incontinence increased. | One month after complete three sessions | Self-reported questionnaires were used to measure pre-Treatment symptom severity and post treatment symptom and severity. |
Countries
Egypt
Outcome results
None listed